PT2331682T - Vacinas contra a bronquite infecciosa derivadas de estirpes de tipo ib-qx - Google Patents

Vacinas contra a bronquite infecciosa derivadas de estirpes de tipo ib-qx

Info

Publication number
PT2331682T
PT2331682T PT09791266T PT09791266T PT2331682T PT 2331682 T PT2331682 T PT 2331682T PT 09791266 T PT09791266 T PT 09791266T PT 09791266 T PT09791266 T PT 09791266T PT 2331682 T PT2331682 T PT 2331682T
Authority
PT
Portugal
Prior art keywords
strains
infectious bronchitis
vaccines derived
bronchitis vaccines
derived
Prior art date
Application number
PT09791266T
Other languages
English (en)
Inventor
Jacob Geerligs Harmen
Aleida Maria Meinders Cindy
Jan Boelm Geert
Geertruida Elisabeth Stuurman Bastiana
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of PT2331682T publication Critical patent/PT2331682T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C12N7/08—Inactivation or attenuation by serial passage of virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20061—Methods of inactivation or attenuation
    • C12N2770/20064—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
PT09791266T 2008-08-08 2009-08-07 Vacinas contra a bronquite infecciosa derivadas de estirpes de tipo ib-qx PT2331682T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8722808P 2008-08-08 2008-08-08

Publications (1)

Publication Number Publication Date
PT2331682T true PT2331682T (pt) 2018-12-19

Family

ID=41211689

Family Applications (1)

Application Number Title Priority Date Filing Date
PT09791266T PT2331682T (pt) 2008-08-08 2009-08-07 Vacinas contra a bronquite infecciosa derivadas de estirpes de tipo ib-qx

Country Status (27)

Country Link
US (1) US9296991B2 (pt)
EP (1) EP2331682B1 (pt)
JP (3) JP2011530294A (pt)
KR (2) KR101732240B1 (pt)
CN (1) CN102239252B (pt)
AR (1) AR072976A1 (pt)
AU (1) AU2009279528A1 (pt)
BR (1) BRPI0917447A2 (pt)
CA (1) CA2732822C (pt)
CL (1) CL2011000262A1 (pt)
CO (1) CO6351810A2 (pt)
CY (1) CY1121567T1 (pt)
DK (1) DK2331682T3 (pt)
ES (1) ES2702089T3 (pt)
HK (1) HK1159164A1 (pt)
HU (1) HUE041481T2 (pt)
LT (1) LT2331682T (pt)
ME (1) ME01270B (pt)
MX (1) MX339731B (pt)
PL (1) PL2331682T3 (pt)
PT (1) PT2331682T (pt)
RU (1) RU2568053C2 (pt)
SI (1) SI2331682T1 (pt)
TR (1) TR201819340T4 (pt)
UA (1) UA103330C2 (pt)
WO (1) WO2010017440A1 (pt)
ZA (1) ZA201100849B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10125401B2 (en) 2012-12-18 2018-11-13 Asia-Pacific Special Nutrients Sdn. Bhd. High resolution melt genotyping of IBV, CSFV and NDV
CN103028112B (zh) * 2012-12-31 2014-08-06 青岛易邦生物工程有限公司 一种鸡新城疫和传染性支气管炎二联活疫苗
CN103146654B (zh) * 2013-03-25 2014-07-30 浙江诺倍威生物技术有限公司 一株人工弱化的鸡传染性支气管炎病毒及其应用
BR112018075033A2 (pt) * 2016-06-02 2019-03-26 Zoetis Services Llc vacina contra bronquite infecciosa
CN108950068B (zh) * 2018-07-18 2021-05-07 浙江大学 一种鸡传染性支气管炎病毒qx型毒株鉴别检测试剂盒
KR20210087058A (ko) * 2018-10-31 2021-07-09 베링거잉겔하임베트메디카게엠베하 이종 스파이크 단백질을 갖는 4/91 ibv 백신
WO2024019579A1 (ko) * 2022-07-22 2024-01-25 주식회사 카브 닭전염성기관지염바이러스 약독화주 및 이를 포함하는 백신조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4867975A (en) * 1988-01-27 1989-09-19 University Of Delaware Live attenuated temperature-sensitive avian infectious bronchitis virus vaccines and preparation and use thereof
US5037650A (en) * 1988-03-08 1991-08-06 Akzo N.V. Live combination vaccine
ES2152292T3 (es) 1993-07-30 2001-02-01 Akzo Nobel Nv Vacuna para aves de corral que contiene el virus de la bronquitis infecciosa 4/91.
JPH07206705A (ja) * 1993-11-03 1995-08-08 American Cyanamid Co 生インオボ（ｉｎ ｏｖｏ）ワクチン
US20010046500A1 (en) 2000-02-29 2001-11-29 Berend Jongsma In ovo protection against infectious bronchitis
BRPI0407948B1 (pt) * 2003-03-03 2014-10-21 Animal Health Inst “vacina para uso na proteção de aves domésticas contra a bronquite infecciosa, método para a preparação da mesma, e, uso da cepa beaudette de ibv”
US7291342B2 (en) * 2003-05-19 2007-11-06 Intervet International B.V. Infectious bronchitis virus vaccine

Also Published As

Publication number Publication date
CN102239252A (zh) 2011-11-09
EP2331682A1 (en) 2011-06-15
CN102239252B (zh) 2015-04-15
ZA201100849B (en) 2015-10-28
RU2011104201A (ru) 2012-08-20
JP6397539B2 (ja) 2018-09-26
MX2011001514A (es) 2011-03-29
KR20110038181A (ko) 2011-04-13
ES2702089T3 (es) 2019-02-27
CY1121567T1 (el) 2020-05-29
CA2732822C (en) 2016-09-20
KR20150020623A (ko) 2015-02-26
US9296991B2 (en) 2016-03-29
CO6351810A2 (es) 2011-12-20
CL2011000262A1 (es) 2011-05-06
US20110305726A1 (en) 2011-12-15
JP2015144605A (ja) 2015-08-13
ME01270B (me) 2013-06-20
SI2331682T1 (sl) 2019-01-31
KR101732240B1 (ko) 2017-05-02
PL2331682T3 (pl) 2019-03-29
AR072976A1 (es) 2010-10-06
LT2331682T (lt) 2018-12-10
DK2331682T3 (en) 2018-12-10
HK1159164A1 (zh) 2012-07-27
UA103330C2 (ru) 2013-10-10
BRPI0917447A2 (pt) 2015-12-01
HUE041481T2 (hu) 2019-05-28
EP2331682B1 (en) 2018-10-24
CA2732822A1 (en) 2010-02-11
MX339731B (es) 2016-06-08
TR201819340T4 (tr) 2019-01-21
WO2010017440A1 (en) 2010-02-11
RU2568053C2 (ru) 2015-11-10
JP2017212976A (ja) 2017-12-07
JP2011530294A (ja) 2011-12-22
AU2009279528A1 (en) 2010-02-11

Similar Documents

Publication Publication Date Title
ZA201101481B (en) Vaccine
HRP20151124T1 (en) Vaccine
IL208660A0 (en) Coccididosis vaccines
PL2358386T3 (pl) Zoptymalizowane szczepionki na grypę
GB0822001D0 (en) Vaccine
HK1159164A1 (zh) -樣病毒株衍生的感染性支氣管炎疫苗
IL212311A0 (en) Immunoenhancer-linked oligomeric hiv vaccines
GB0810710D0 (en) Vaccine
ZA201007402B (en) Vaccine
EP2326671A4 (en) LPS BASED VACCINES
GB0816284D0 (en) Vaccine
ZA201100962B (en) Influenza vaccines
GB0907935D0 (en) Vaccines
ZA201100889B (en) Vaccine against hpv
GB0816447D0 (en) Vaccine
GB0801326D0 (en) Vaccines
EP2337847A4 (en) ADJUVANTS FOR VACCINES
EP2240199A4 (en) INFLUENZA VACCINES
EP2331119A4 (en) MALARIA VACCINE
GB0818459D0 (en) Vaccines
GB0806461D0 (en) Anti-atheroma vaccine
GB0809781D0 (en) Vaccine
GB0810914D0 (en) Vaccine
GB0810215D0 (en) Vaccine
GB0820478D0 (en) Vaccine